|
End-of-day quote
Korea S.E.
2026-10-23
|
5-day change | 1st Jan Change | ||
| 1,620.00 KRW | 0.00% |
|
+9.53% | -14.69% |
Company Valuation: Genolution Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 87,181 | 73,594 | 40,175 | 34,308 |
| Change | - | -15.58% | -45.41% | -14.6% |
| Enterprise Value (EV) 1 | 57,676 | 54,278 | 31,225 | 30,423 |
| Change | - | -5.89% | -42.47% | -2.57% |
| P/E | 5.85x | -12.8x | -5.89x | -2.95x |
| PBR | 0.85x | 0.79x | 0.5x | 0.5x |
| PEG | - | 0x | -0.2x | -0x |
| Capitalization / Revenue | 2.29x | 7.54x | 5.63x | 3.65x |
| EV / Revenue | 1.51x | 5.56x | 4.38x | 3.23x |
| EV / EBITDA | 3.59x | -9.85x | -4.38x | -4.85x |
| EV / EBIT | 3.91x | -7.65x | -3.41x | -3.52x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | 768.9 | -300.4 | -378 | -644.5 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 38,085 | 9,761 | 7,136 | 9,404 |
| EBITDA 1 | 16,065 | -5,513 | -7,123 | -6,279 |
| EBIT 1 | 14,737 | -7,091 | -9,164 | -8,642 |
| Net income 1 | 14,602 | -5,512 | -6,826 | -11,643 |
| Net Debt 1 | -29,504 | -19,316 | -8,950 | -3,886 |
| Reference price 2 | 4,500.00 | 3,835.00 | 2,225.00 | 1,899.00 |
| Nbr of stocks (in thousands) | 19,373 | 19,190 | 18,056 | 18,067 |
| Announcement Date | 3/21/24 | 3/21/24 | 3/20/25 | 3/19/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 22.09M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 8x | 26.2x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| Average | 26.77x | 26.46x | 15.68x | 0.32% | 38.31B | |
| Weighted average by Cap. | 26.72x | 25.33x | 15.90x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A225220 Stock
- Valuation Genolution Inc.
Select your edition
All financial news and data tailored to specific country editions
